focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNLG.L Regulatory News (NLG)

  • There is currently no data for NLG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of 7th US Patent

25 Feb 2016 13:00

RNS Number : 1762Q
Arria NLG PLC
25 February 2016
 

25 February 2016

Arria NLG plc("Arria NLG" or the "Company")

Grant of 7th US Patent

 

Arria NLG plc (AIM:NLG), a technology leader in Natural Language Generation ("NLG"), is to be granted a patent on its Method And Apparatus For Referring Expression Generation from the US Patent and Trademark Office, it's seventh to date. The Company's Chief Scientist, Prof. Ehud Reiter, created this important new feature of the Arria NLG Platform.

The new patent covers an essential component of Arria NLG's products for information analysis and delivery. The Company's products automate the real-time analysis and delivery of reports, whilst also generating language that follows intuitive rules for how humans communicate and comprehend information.

The innovations embodied in the new patent allow a report's second or subsequent mention of a complex machine, device or process to be expressed in a word or two, rather than by its full name. For example, the operator of an electrical power plant, who receives the actionable intelligence contained in an Arria NLG report, is not required to read in full repeated references to the same components of a particular machine after the report establishes that this component of this machine is being discussed.

In addition, when using referring expression generation, the patented system can flexibly describe details such as a high temperature warning on a rotor shaft to an engineer. For example, the system is able to recite: "temperature is high," when a previous sentence has provided the reader with the necessary context to understand that the text is referring to a rotor shaft on a specific machine. The system likewise intelligently adapts the expression to recite: "rotor shaft temperature is high," when a previous sentence lacked sufficient context. In each instance, the system can adapt sentences as the report is generated so as to eloquently describe components and subcomponents of a complex machine.

This seventh Arria NLG patent covers the generation of referring expressions not only within the Company's advanced NLG systems but also in more rudimentary systems relying on the infilling of templates (akin to mail-merge) that are in common use.

Arria NLG's patents and patent applications cover critical NLG processes that the Company currently applies to innovative applications delivered to its growing list of global clients, as well as to a range of SaaS-delivered packaged applications that are in development for a number of markets. The patents also apply to the Company's proprietary Software Development Toolkit ("SDK"). Arria NLG's expanding patent portfolio strengthens its plan to become the global leader in automating data analysis and information delivery in any industrial or consumer setting.

Stuart Rogers, Chairman and Chief Executive of Arria NLG, stated: "We believe that there are two key areas where this patent raises the bar in the quality of 'humanized' text generated from NLG technology. Firstly, anyone who wants to build an NLG system that communicates with users in a human manor is likely to need to implement the technology that this patent covers into their systems. Secondly, anyone wanting the Internet of Things to successfully talk naturally to users will likely need this technology.

This is our seventh patent in the US and a core element for advanced NLG technology and one which Arria NLG are very proud to own. This patent is linked to our previous patents, the technology for which can all be found in our NLG Platform. This technology is already available to our customers and will also be provided in a dynamic natural language toolkit when our Software Development Kit 4.5 is product released this year."

 

For further information, please visit www.arria.com or contact:

 

Arria NLG plc

Stuart RogersChairman and Chief Executive

Tel +44 (0)20 7100 4540

Allenby Capital Nominated Adviser & Joint Broker

Nick Naylor

Jeremy Porter

James Reeve

Tel: +44 (0)20 3328 5656

MSL Capital Markets Lead Manager

Andrew McDouall

Justine Dunnett

Peter Lynds

Tel: +64 (0)4 472 2716

Stockdale Securities

Joint Broker

Antonio Bossi

Robert Finlay

Tel: +44 (0)20 7601 6100

IFC Advisory Financial PR and IR

Tim Metcalfe

Graham Herring

Heather Armstrong

Tel: +44 (0)20 3053 8671

tim.metcalfe@investor-focus.co.uk

graham.herring@investor-focus.co.uk

heather.armstrong@investor-focus.co.uk

Ruder Finn PR (USA)

Scott Beaver (West Coast)

Brianna Mulligan (East Coast)

 

Tel: +1 541-326-5847

Tel: +1 203-246-1304

 

Arria NLG

 

Arria NLG's core product is known as the Arria NLG Platform, a form of artificial intelligence software, specialised in extracting information from complex data sources and communicating that information in natural language (i.e. as if written by a human). The scientific foundation for the Arria NLG Platform is based on more than 30 years of research and development by the Data2Text Founders at the University of Aberdeen. For additional information, visit www.arria.com. Follow Arria NLG on Twitter, LinkedIn, Google+ and YouTube.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLELFLQLFZBBD
Date   Source Headline
19th Jan 20177:00 amRNSCompany update
6th Jan 201710:32 amRNSResult of General Meeting
19th Dec 20163:03 pmRNSRecount Product Launch UK
19th Dec 20167:00 amRNSProposed cancellation of trading on AIM
7th Dec 20167:00 amRNSHolding(s) in Company
1st Dec 20168:45 amRNSTimetable and Progress to NZ and Australia IPO
21st Nov 20168:00 amRNSUpdate on Loan Note Subscriptions
7th Nov 20164:35 pmRNSPrice Monitoring Extension
31st Oct 20164:14 pmRNSUpdate on trading and proposed NZX listing
24th Oct 20167:00 amRNSFinancing update
13th Oct 20168:30 amRNSDirectorate Changes
5th Oct 20167:00 amRNSProduct Launch - Articulator Lite
3rd Oct 20167:00 amRNSFinancing update
13th Sep 20167:00 amRNSPartnership agreement with GeoCosmo Sciences SPC
5th Sep 20164:35 pmRNSPrice Monitoring Extension
31st Aug 20167:00 amRNSProduct Launch
8th Aug 20167:00 amRNSBoard Changes
18th Jul 20168:00 amRNSIssue of Loan Notes
12th Jul 20167:00 amRNSFurther pilot programmes secured
4th Jul 20169:00 amRNSProposed NZSX & ASX listings
17th Jun 20164:40 pmRNSSecond Price Monitoring Extn
17th Jun 20164:35 pmRNSPrice Monitoring Extension
16th Jun 20164:35 pmRNSPrice Monitoring Extension
15th Jun 20167:29 amRNSHalf Year Results
10th Jun 20167:00 amRNSListing and fundraising update
1st Jun 20167:00 amRNSImplementation and Licence Agreement
26th May 20167:00 amRNSGrant of 9th US Patent
16th May 20167:00 amRNSGrant of 8th US Patent
21st Mar 201610:37 amRNSPartnership Agreement with INOVX
18th Mar 20164:40 pmRNSSecond Price Monitoring Extn
18th Mar 20164:35 pmRNSPrice Monitoring Extension
18th Mar 20161:57 pmRNSFundraising Update
25th Feb 20161:00 pmRNSGrant of 7th US Patent
23rd Feb 20161:06 pmRNSHolding(s) in Company
18th Feb 20162:48 pmRNSDirectorate Change
12th Feb 20164:20 pmRNSHolding(s) in Company
12th Feb 20164:20 pmRNSHolding(s) in Company
11th Feb 20165:05 pmRNSHolding(s) in Company
3rd Feb 20167:00 amRNSGrant of 6th US Patent
29th Jan 20166:00 pmRNSTotal Voting Rights
28th Jan 201611:37 amRNSResult of AGM
25th Jan 20167:00 amRNSExercise of Options
11th Jan 20164:35 pmRNSPrice Monitoring Extension
11th Jan 20167:00 amRNSGrant of 5th US Patent
4th Jan 20167:00 amRNSFramework Agreement with Major US Utility Company
30th Dec 20157:00 amRNSGrant of Share Options
22nd Dec 20157:00 amRNSFramework Agreement with Genpact
11th Dec 20157:00 amRNSFinal Results for the year ended 30 September 2015
30th Nov 20155:40 pmRNSTotal Voting Rights
18th Nov 201511:54 amRNSUpdate on issue of convertible notes & warrants

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.